Norges Bank’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.1M | Buy |
+169,000
| New | +$1.1M | ﹤0.01% | 1527 |
|
2025
Q1 | – | Sell |
-169,000
| Closed | -$2.14M | – | 455 |
|
2024
Q4 | $2.14M | Buy |
+169,000
| New | +$2.14M | ﹤0.01% | 1683 |
|
2024
Q3 | – | Sell |
-169,000
| Closed | -$2.33M | – | 462 |
|
2024
Q2 | $2.33M | Hold |
169,000
| – | – | ﹤0.01% | 1696 |
|
2024
Q1 | $2.79M | Hold |
169,000
| – | – | ﹤0.01% | 1706 |
|
2023
Q4 | $2.47M | Hold |
169,000
| – | – | ﹤0.01% | 1777 |
|
2023
Q3 | $2.07M | Hold |
169,000
| – | – | ﹤0.01% | 1821 |
|
2023
Q2 | $2.02M | Hold |
169,000
| – | – | ﹤0.01% | 1869 |
|
2023
Q1 | $2.26M | Buy |
169,000
+61,000
| +56% | +$816K | ﹤0.01% | 1908 |
|
2022
Q4 | $2.32M | Buy |
+108,000
| New | +$2.32M | ﹤0.01% | 1947 |
|